Novartis personalized cell therapy CTL019 receives FDA Breakthrough Therapy designation

Novartis personalized cell therapy CTL019 receives FDA Breakthrough Therapy designation

Jul 07, 2014
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-personalized-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-0